| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $38.7M | -17.5% |
| Cost of Revenue | $14.6M | -14.1% |
| Gross Profit | $24.1M | -19.4% |
| R&D Expense | $642K | -5.0% |
| SG&A Expense | $9.5M | -0.1% |
| Operating Income | $4.1M | -49.6% |
| Pre-tax Income | $3.8M | -45.7% |
| Income Tax | -$21.2M | — |
| Net Income | $24.6M | +266.7% |
| EPS (Basic) | $5.55 | +290.8% |
| EPS (Diluted) | $0.89 | +122.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.5M | +71.5% |
| Accounts Receivable | $5.6M | -33.9% |
| Inventory | $1.1M | -8.0% |
| Current Assets | $9.9M | -15.9% |
| Total Assets | $33.8M | +128.8% |
| Current Liabilities | $5.1M | -51.9% |
| Total Liabilities | $11.5M | -32.5% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $5.8M | +25.5% |
| Capital Expenditures | $356K | -59.4% |
| Investing Cash Flow | -$356K | +59.4% |
| Financing Cash Flow | -$4.4M | +23.7% |
| Free Cash Flow | $5.5M | +45.2% |
| $22.4M |
| +1108.7% |